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ImagingPrevious studies have reported alterations in greymatter volume and cortical thickness in individuals at high risk
of developing psychosis and patients in the early stages of the disorder. Because these studies have typically fo-
cused on either greymatter volume or cortical thickness separately, the relationship between these two types of
alterations is currently unclear. In the present investigation we used both voxel-based cortical thickness (VBCT)
and voxel-based morphometry (VBM) to examine neuroanatomical differences in 21 individuals with an At Risk
Mental State (ARMS) for psychosis, 26 patients with a First Episode of Psychosis (FEP) and 24 healthy controls.
Statistical inferences were made at P b 0.05 after correction for multiple comparisons. Cortical thinning in the
right superior temporal gyrus was observed in both individuals at high risk of developing psychosis and patients
with a ﬁrst episode of the disorder, and therefore is likely to represent a marker of vulnerability. In contrast, the
right posterior cingulate cortex showed cortical thinning in FEP patients relative to individuals at high risk, and
therefore appears to be implicated in the onset of the disease. These neuroanatomical differenceswere expressed
in terms of cortical thickness but not in terms of grey matter volume, and therefore may reﬂect speciﬁc cortical
atrophy as opposed to variations in sulcal and gyral morphology.
© 2013 The Authors. Published by Elsevier B.V.Open access under CC BY-NC-SA license. 1. Introduction
There is increasing interest in the investigation of neuroanatomical
alterations in clinically healthy individuals at high risk for psychosis
and patients in the early stages of the disorder, in order to develop po-
tential biomarkers for early diagnosis. The vast majority of the studies
have examined neuroanatomical alterations by measuring grey matter
volume (GMV) using voxel-based morphometry (VBM) (Kubicki et al.,
2002; Pantelis et al., 2003; Narr et al., 2005; Borgwardt et al., 2007b;
Borgwardt et al., 2008; Meisenzahl et al., 2008; Witthaus et al., 2009;
Mechelli et al., 2011); in addition, a smaller number of studies have
measured cortical thickness(CT) using a cortical surface-based approach
(Wiegand et al., 2004; Fornito et al., 2008; Schultz et al., 2010; Ziermanstudies, PO Box 67, Institute of
ondon SE5 8AF, UK. Tel.: +44
.Open access under CC BY-NC-SA licenet al., 2010; Jung et al., 2011). With regard to patients in the early stages
of psychosis, consistent GMV and CT alterations have been reported
in medial and lateral temporal regions and, to a lesser extent, dorso-
lateral prefrontal and cingulate regions (Kubicki et al., 2002; Wiegand
et al., 2004; Narr et al., 2005; Fornito et al., 2008; Witthaus et al., 2009;
Schultz et al., 2010; Bodnar et al., 2011; Jung et al., 2011).With regard
to individuals at high risk of developing the disorder, GVM and CT alter-
ations have been reported in frontal, cingulate and temporal regions
(Borgwardt et al., 2007b; Witthaus et al., 2009; Ziermans et al., 2010;
Jung et al., 2011).
The studies published so far have typically focused on either grey
matter volume or cortical thickness separately; however these two
measurements reﬂect complementary aspects of neuroanatomy and
may provide different sensitivity depending on the pathophysiological
process under investigation. More speciﬁcally, the analysis of cortical
thickness targets the presence of speciﬁc cortical atrophy, whereas the
analysis of greymatter volume returns amixedmeasurewhich depends
on local cortical thickness as well as cortical folding and gyriﬁcation
(i.e. cortical surface area) (Hutton et al., 2008). Thus, when used in
combination, GMV and CT measurements provide more comprehen-
sive information about the underlying pathophysiological changes.se. 
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early phases of psychosis (Voets et al., 2008; Takayanagi et al., 2011);
these have reported discrepant ﬁndings as to whether GMV and CT
alterations are expressed in similar or different areas. More speciﬁcally,
Takayanagi et al. (2011) observed reduced CT and GMV in prefrontal
and temporal regions in patients with a ﬁrst episode of psychosis
(Takayanagi et al., 2011). In contrast, Voets and colleagues showed
widespread but focally distinct patterns of CT and GMV alterations in
adolescents with early-onset schizophrenia (Voets et al., 2008). More-
over, to the best of our knowledge, no previous study has examined
both aspects of neuroanatomy in both patients with a ﬁrst episode of
psychosis (FEP) and individuals at high risk of developing the disorder.
In the present study we therefore employed both voxel-based CT
(VBCT; Hutton et al., 2008) and voxel-based morphometry (VBM;
Ashburner and Friston, 2000) to investigate neuroanatomical alter-
ations in patients with a ﬁrst episode of psychosis (FEP) and individuals
with an at risk mental state (ARMS) for psychosis relative to healthy
controls. These two analytical techniques were chosen because they
use the same pre-processing and registration procedures and allow
the identiﬁcation of voxel-level GMV and CT alterations within the
same volumetric space, thereby minimizing any potential confounding
methodological differences (Hutton et al., 2009; Nagy et al., 2011).
Ourmain aimwas to examinewhether GMV and CT alterations precede
the clinicalmanifestation of psychosis and therefore represent neuroan-
atomical markers of vulnerability to this disorder. We hypothesized
that (1) both individuals with an ARMS and FEP patients would present
with common cortical alterations in a network of interest comprising
frontal, temporal and cingulate regions and (2) FEP patients would
show more pronounced alterations compared to ARMS individuals inTable 1
Demographic and clinical characteristics of the 70 participants.
Healthy controls
(n = 23)
At risk m
(n = 21)
Age (s.d.) 24.2 (4.2) 22.14 (3.
Male/female 12 M:11 F 9 M:12 F
Premorbid IQ (s.d.) 108.8 (10.13) 101.5 (13
Antipsychotic medication 23 N 2 M:19 N
Total intracranial volume cm3 (s.d.) 1537 (187) 1538(190
Psychophatology scores, mean (s.d.)
PANSS total NA 52.57 (9.
PANSS positive NA 12.89 (3.
PANSS negative NA 14 (4.08)
PANSS hallucinations NA 2.73 (1.3
PANSS delusions NA 2.68 (1.6
CAARMS total NA 39.47(15
CAARMS intake criteria for ARMS
Global functioning and trait markers,
No. (%) of subjects
2 (9.5)
Attenuated psychotic symptoms,
No. (%)
19 (90.5)
Brief limited intermittent psychotic symptoms, No. (%) 2 (9.5)
Clinical outcome for ARMS (24 months)
Individuals with ﬁnished follow-up, No. (%) 9 (42.8)
With transition, No. (%) 0
Without transition, No. (%) 9(42.8)
Drops-out/Unﬁnished follow-up, No. (%) 12(57.2)
Clinical outcome for FEP (12 months)
Schizophrenia/ongoing psychosis, No.
Remission/stable mental state, No.
Schizoaffective disorder, No.
Mood disorder, No.
Drops-out, No.
Abbreviations: PANSS, Positive and Negative Syndrome Scale; CAARMS, Comprehensive Assess
a ARMS versus FEP.
b Healthy controls versus FEP.these regions. Our secondary aim was to examine whether VBM and
VBCT would reveal distinct or similar alterations within our network
of interest. We expected that the two techniques would reveal focally
distinct GMV and CT effects, reﬂecting different underlying pathophys-
iological processes.
2. Methods
2.1. Participants
The study was approved by the local Research Ethics Committee.
Participants gave written informed consent after a full description
of the aims and design of the study. The following exclusion criteria ap-
plied to all participants: (i) a history of neurological disorders; (ii) head
trauma resulting in loss of consciousness for over 1 h; (iii) evidence of
substance abuse and dependence disorder according to the DSM-IV
criteria and (iv) suspected or conﬁrmed pregnancy. All but one subject
in each group were right-handed, while English was the ﬁrst and native
language of all the participants in this study.
2.1.1. First episode psychosis (FEP) group
Twenty-six subjects were recruited from early intervention services
within the South London and Maudsley National Health Trust. All indi-
viduals presented for the ﬁrst time to the local psychiatric services
and met ICD-10 criteria schizophreniform psychosis (WHO, 1992).
One patient only was medication naive while the remaining had been
treated for a mean of 155 days at chlorpromazine equivalent mean
dose of 242 mg/day. See Table 1 for the demographic characteristics of
this sample.ental state First episode psychosis
(n = 26)
Statistics
3)a 26.08 (5.63)a F = 4.227p = 0.019
18 M:8 F χ2 = 2.60, n.s.
.5) 101.81 (11.2) F = 2.924 p = 0.06
24 M:2 Nb χ2 = 54.32 p = 0.001
) 1520(148) F = 0.78, n.s.
0) 54.69 (14.5) t = −0.55, n.s.
6) 13.42 (5.2) t = −0.378, n.s
13.96 (4.9) t = 0.028, n.s.
) 1.92 (1.23) t = 2.09 p = 0.043
2) 3.00 (1.62) t = −0.723, n.s.
.63) NA
12 (46.1)
13 (50)
0
0
1 (3.9)
ment of At Risk Mental State; No., number.
Table 2
Brain regions showing signiﬁcant cortical thinning and grey matter volume reductions in
ARMS and FEP individuals compared to healthy controls, and in FEP compared to ARMS
individuals.
Region Cluster size (K) Z MNI coordinates
x y z
Cortical thickness (effects signiﬁcant at P b 0.05 corrected)
Controls N ARMS & FEP
Superior temporal gyrus R 88 4.47 43 −27 9
ARMS N FEP
Posterior cingulate R 68 4.70 4 −42 21
Grey matter volume (trends signiﬁcant at P b 0.001 uncorrected)
Controls N ARMS & FEP
Parahippocampus R 84 4.19 24 −15 −31
Middle frontal gyrus L 99 4.19 −38 25 33
Anterior cingulate R 72 4.14 3 46 8
ARMS N FEP
Middle temporal gyrus L 11 3.32 −66 −21 0
Superior temporal gyrus R 15 3.30 48 −15 −9
R, right; L, left.
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Twenty-one individuals meeting the Personal Assessment and Crisis
Evaluation (PACE) criteria for the ARMS (Yung et al., 1998) on the basis
of the Comprehensive Assessment for the ARMS (CAARMS; Yung et al.,
2003a) were recruited through the Outreach and Support in South
London (OASIS) service. Two ARMS participants only had been treated
with antipsychotic medication (at chlorpromazine equivalent mean
dose of 76.68 mg/day over the 18 months prior the MRI scan) while
the remaining 17 subjects were medication naive. See Table 1 for the
demographic characteristics of this sample.
2.1.3. Controls
Twenty-four healthy volunteers were recruited by advertisement
from the local community. Additional exclusion criteria included (i) a
current or past history of psychiatric illness, and (ii) the presence of psy-
chosis in ﬁrst-degree relatives. See Table 1 for the demographic charac-
teristics of this sample.
2.2. Clinical assessment
The Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987)
was used to assess the presence and severity of symptoms in the clinical
groups on the day of scanning while the Prodromal Questionnaire
(Loewy et al., 2005) was used to conﬁrm the absence of any psychotic
syndromes in healthy volunteers. The general premorbid intellectual
function was estimated using the reading subtest of the Wide Range
Achievement (WRAT-R; Jastak and Wilkinson, 1984). The clinical char-
acteristics for the three groups are reported in Table 1.
2.3. MRI analysis
2.3.1. MRI data acquisition
T1-weighted images were acquired on a 3.0 T GE Signa system
(GE Medical Systems, Milwaukee), at the Maudsley Hospital, London,
using a fast Spoiled Gradient Recalled (FSPGR) in Steady State sequence.
Image acquisition parameters were: 1.1 mm thick coronal slices, TR/TE/
TI = 28.32/7.08/450 ms, 20˚ ﬂip angle and ﬁeld of view 21 cm. For each
subject, 196 coronal partitions were acquired with an image matrix
of 256 × 256 (Read × Phase) providing whole-brain anatomical data
with an anisotropic spatial resolution of 1.09 × 1.09 × 1.1 mm3.
2.3.2. MRI data processing
The uniﬁed segmentation procedure (Ashburner and Friston, 2005)
implemented in SPM8 (http://www.ﬁl.ion.ucl.ac.uk/spm) was used to
segment all the images into grey matter (GM), white matter (WM)
and cerebrospinal ﬂuid (CSF) partitions.
2.3.2.1. Creation of voxel-based grey matter volume maps. A fast
diffeomorphic image registration algorithm (DARTEL) was used to
warp the GM partitions into a new study-speciﬁc reference space with
an isotropic spatial resolution of 1.5 mm3 (Ashburner and Friston,
1997, 2009; Ashburner, 2007). The warped GM partitions were then
afﬁne transformed into the MNI space. An additional ‘modulation’ step
(Good et al., 2001) was used to scale the GM probability values by the
Jacobian determinants of the deformations to ensure that the total
amount of grey matter in each voxel was conserved after the registra-
tion. As a ﬁnal step the GM probability maps were smoothed using a
6 mm FWHM Gaussian kernel.
2.3.2.2. Creation of voxel-based cortical thickness maps. A voxel-based
Laplacian method (Jones et al., 2000; Hutton et al., 2008) was used to
create a VBCTmap for each subject using theGM,WMandCSF partitions
created in the segmentation step. The resulting VBCTmaps contained CT
values within voxels identiﬁed as GM and zeros outside the cortex and
were saved in the native space of the input images (1 mm3 resolution).
Each VBCT map was warped into the new DARTEL reference spaceby applying the corresponding subject speciﬁc deformation ﬁeld and
resampled to an isotropic voxel size of 1.5 mm3. The warped images
were then scaled by the Jacobian determinant of the deformation and
smoothed with a 6 mm Gaussian kernel. The same warps, modulation
and smoothing were also applied to a binary mask created from each
original VBCT map. Subsequently the warped, scaled and smoothed
VBCT maps were divided by the corresponding warped, scaled, and
smoothedmask. The effect of this procedurewas to project the Gaussian
smoothing kernel applied to the warped images, into the native space
of the subject while preserving the CT value over a region the size of
the smoothing kernel.
2.3.3. Statistical analysis
The statistical analysis focused on a bilateral network of interest
which included regions reported to show alterations of grey matter
density or CT in individuals with an ARMS and patients with FEP in pre-
vious studies (Wiegand et al., 2004; Narr et al., 2005; Fornito et al.,
2008; Schultz et al., 2010; Ziermans et al., 2010; Jung et al., 2011).
These regions included the (1) inferior frontal gyrus (IFG), (2) middle
frontal gyrus (MFG), (3) anterior and posterior cingulate cortex (ACC
and PCC), (4) superior temporal gyrus (STG), (5) middle temporal
gyrus (MTG) and (6) parahippocampal cortex (PHC). Using the auto-
mated anatomical labelling (AAL) system as implemented in PickAtlas
toolbox (www.nitrc.org/projects/wfu_pickatlas), we constructed a mask
that comprised of all these regions (total volume: 61,107 voxels). Two
voxel-wise Analyses of Covariance (ANCOVAs) were performed on the
GMV and CT separately; for each independent ANCOVA the GMV or
the CT was entered as the dependent variable and the experimental
groups as the independent and between-subject variable. The total
intracranial volume (TIV) was calculated for each subject by summing
together the voxel values of the original GM, WM and CSF tissue parti-
tions. Age, gender and TIV were included as covariates of no interest
to explain variance associated with these potentially confounding
effects. We identiﬁed regions that showed cortical alterations in
both ARMS and FEP relative to healthy controls by comparing the
combined ARMS and FEP group against controls and inclusively
masking (at P b 0.001) the results with the individual comparisons be-
tween the ARMS group and controls and between the FEP group and
controls. This procedure allowed us to identify those signiﬁcant voxels
in the main contrast (i.e. ARMS and FEP groups against controls) that
were also signiﬁcant in each of the two individual contrasts speciﬁed
as mask (i.e. ARMS group against controls and FEP group against con-
trols respectively).
Statistical inferences were made at P b 0.05 after Family-Wise Error
(FWE) correction formultiple comparisons.When signiﬁcantdifferences
were not detected, we tested for the presence of trends for completeness
Fig. 1. Left. Brain regions showing cortical thinning in both ARMS and FEP participants compared to healthy controls (P b 0.001uncorrected, for display purposes). T-scores are shown in
the coloured bar. Right. Cortical thickness (CT) estimates in the right superior temporal cortex are shown for the three groups with the dashed lines indicating group CT means. Cortical
thickness is measured in terms of mm between the inner and outer surfaces of grey matter.
508 S. Benetti et al. / Schizophrenia Research 150 (2013) 505–511by lowering the statistical threshold to P b 0.001 (uncorrected). How-
ever our discussion focuses on those differences that were signiﬁcant
after correction for multiple comparisons.
3. Results
3.1. Voxel-wise differences in cortical thickness
Compared to healthy controls, individuals with an ARMS and FEP
patients showed thinner cortex in the right STG (BA 42) (P b 0.05,Fig. 2. Left. Brain regions showing cortical thinning in FEP patients compared to ARMS partic
map. Right. Cortical thickness (CT) estimates in the right posterior cingulate cortex are shown
is measured in terms of mm between the inner and outer surfaces of grey matter.corrected; Table 2; Fig. 1). In contrast, therewere no regionswith thicker
cortex in the two clinical groups compared to the control group. When
the ARMS and FEP groups were compared, the latter showed reduced
CT in the right PCC (P b 0.05, corrected; Fig. 2; Table 2); in contrast, no
areas showed an effect in the opposite direction.
3.2. Voxel-wise differences in grey matter volume
There were no regions showing grey matter increases in the two
clinical groups compared to healthy controls. At a lower statisticalipants (P b 0.001 uncorrected, for display purposes). T-scores are shown in the coloured
for the three groups with the dashed lines indicating group CT means. Cortical thickness
Table 3
Correlations between cortical thicknessmeasurements, clinical characteristics,medication
indices and age (P b 0.05, two tailed).
FEP & ARMS
R STG (CT)
(43−27 9)
FEP
R STG (CT)
(43−27 9)
ARMS
R STG (CT)
(43−27 9)
FEP
R PCC (CT)
(4−42 21)
r P r P r P r P
PANSS positive − .016 .918 − .148 .471 .206 .370 − .117 .570
PANSS negative − .156 .294 − .125 .544 − .255 .264 − .258 .203
PANSS total − .033 .827 − .064 .758 .036 .877 − .172 .402
PANSS hallucinations − .095 .524 − .380 .056 − .020 .931 − .146 .477
PANSS delusions − .051 .734 − .125 .544 .123 .595 − .155 .450
Mean CPZ – – − .087 .672 – – .246 .225
Cumulative CPZ – – .107 .604 – – .339 .091
Mean age .095 .524 .239 .240 .004 .986 .214 .237
R STG, right Superior Temporal Gyrus; R PCC, right posterior cingulate cortex; CT, cortical
thickness; ARMS, ARMS group; FEP, FEP group; FEP & ARMS, FEP and ARMS groups
combined; PANSS, Positive And Negative Syndrome Scale; CPZ, chlorpromazine equiva-
lent dose.
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grey matter reduction common to both ARMS and FEP subjects relative
to healthy controls in three brain regions (Table 2). When FEP patients
were compared to ARMS individuals, again no signiﬁcant GMV differ-
ences were observed in either direction. At a lower statistical thresh-
old of P b 0.001 (uncorrected) we detected a trend for decreased
grey matter in the left MTG and in the right STG in the FEP compared
to the ARMS group (Table 2). The two regions showing signiﬁcant
effects for CT, i.e. the right STG and PCC, did not show similar effects
for GMV even when lowering the statistical threshold to P b 0.05
(uncorrected).
3.3. Correlations analyses
In order to better characterize the above ﬁndings, Pearson's correla-
tion coefﬁcients were used to examine whether CT values in the right
STG and right PCC were associated with PANSS scores, age or cumula-
tive and mean doses of antipsychotic medication. A total of 28 correla-
tion analyses were performed and no signiﬁcant associations were
detected (P b 0.05, two tailed; Table 3).
4. Discussion
The present study used two complementary analytical techniques
for assessing voxel-based GMV (Ashburner and Friston, 2000) and
voxel-based CT (Hutton et al., 2008) in individuals at high risk of
psychosis and patients with FEP. We hypothesized that ARMS and FEP
patients would present with common reductions within a network
of interest comprising frontal, temporal and cingulate regions. This
hypothesiswas conﬁrmed only in part, since both ARMS and FEP groups
showed signiﬁcant cortical thinning in the right STG (P b 0.05, FWE
corrected) but only trends for GMV decreases in the right ACC,
right PHC and left MFG (P b 0.001, uncorrected). A previous study had
reported reduced CT in the right STG of patients with FEP relative to
healthy controls (Gutierrez-Galve et al., 2010). Our investigation repli-
cates this ﬁnding and furthermore indicates that reduced CT in this
region may be best explained in terms of enhanced vulnerability rather
than the onset of the disorder. The cortical thinning of the right STG
observed in the ARMS and FEP groups could be mediated by genetic
inﬂuences on brain development, consistent with the observation
that CT is highly heritable (Panizzon et al., 2009; Winkler et al., 2010),
or alternatively it could be the result of adverse life events, consistent
with growing evidence of experience-dependent neuroplasticity in
the human brain (Heim et al., 2013). All the ARMS participants included
in this study had an elevated risk of developing full-blown psychosis,
because they had presented with attenuated psychotic symptoms
or brief limited intermittent psychotic symptoms within 3 monthsbefore study inclusion (Ruhrmann et al., 2003; Hafner et al., 2004). In
contrast, all FEP participants met ICD-10 criteria schizophreniform
psychosis.
We also hypothesized that FEP patients would show more pro-
nounced alterations compared to ARMS individuals within our network
of interest; consistent with this hypothesis, we found a signiﬁcant
CT reduction in the FEP relative to the ARMS group in the right PCC.
Thus cortical thinning in this region appears to be associated with
the onset of the disorder rather than vulnerability. A previous study re-
ported that, when using a conservative statistical threshold of P b 0.05
(FWE-corrected), the only region to show a signiﬁcant GMV reduction
in patients with FEP relative to individuals at ultra high risk for psychosis
was the middle/posterior cingulate (Witthaus et al., 2009). Our
investigation expands the results of this earlier study by indicating that
differences between ARMS and FEP in the PCC are likely to reﬂect
speciﬁc cortical atrophy as opposed to variations in sulcal and gyral mor-
phology. This conclusion is supported by a recent investigation that
found widespread cortical thinning in patients with chronic schizophre-
nia relative to individuals at ultra high risk for the disorder in a
distributed network which included the right PCC (Jung et al., 2011).
Our ﬁnal hypothesis was that VBM and VBCT would reveal focally
distinct GMV and CT alterations, reﬂecting different underlying patho-
physiological processes. This hypothesis was conﬁrmed in part, since
VBCT revealed speciﬁc cortical atrophy in the right STG (in the FEP
and ARMS groups relative to the control group) and the right PCC
(in the FEP relative to the ARMS group), whereas VBM only detected
trends for GMV decreases in the right ACC, left MFG and left PHC.
No differences in GMV were detected in the right STG and right PCC
even when lowering the statistical threshold to P b 0.05 (uncorrected).
One possible hypothesis is that progressive cortical atrophy in ARMS
and FEP individuals might reﬂect an abnormal acceleration of cortical
developmental processes (Thompson et al., 2001; Jung et al., 2011).
This would be consistent with the recent observation of progressive
cortical thinning in the left MTG of adolescents at high risk of psychosis
over time in the absence of signiﬁcant differences in GMV (Ziermans
et al., 2010). In order to elucidate the above hypothesis, we evaluated
whether there was a signiﬁcant negative correlation between CT values
and age in the right STG of ARMS and FEP participants; however, we
found no evidence of such an association (p b 0.05). Future longitudinal
studies with larger sample sizes would be needed to better evaluate
the hypothesis of abnormal acceleration of cortical developmental pro-
cesses in these clinical groups.
This study has three main limitations. First, the number of ARMS
and FEP participants included in this investigation was relatively small
(n = 21 and n = 26 respectively). However, previous studies showing
signiﬁcant differences in these populations included samples of compa-
rable size (Kubicki et al., 2002; Wiegand et al., 2004; Borgwardt et al.,
2007a; Witthaus et al., 2009). Furthermore, a recent analysis of effect
size in classical inference has suggested that, in order to optimize
the sensitivity to large effects while minimizing the risk of detecting
trivial effects, the optimum sample size for a study is 16 (Friston,
2012). Nevertheless, a larger ARMS sample would have permitted to
better elucidate neuroanatomical alterations associated with different
levels of vulnerability to psychosis. Secondly, the present study was
not designed as a longitudinal investigation and therefore we cannot
provide deﬁnite information as to the rate of transition to psychosis in
our ARMS group. In contrast to transition rates previously reported
(Yung et al., 2003b; Olsen and Rosenbaum, 2006), none of the ARMS
participants completing the 24 months follow-up (9 out of 21) made
transition to a full-blown psychosis. This inconsistency might be due
to the small and unrepresentative sample of ARMS who completed
the follow-up, the impact of clinical treatment provided by early inter-
vention services as well as the duration of the follow-up period. For
instance, it has been recently proposed that longer follow-up periods
are associated with higher risk of transition (Fusar-Poli et al., 2012)
and that 33% of converters have prodromal phases lasting longer
510 S. Benetti et al. / Schizophrenia Research 150 (2013) 505–511than 6 years (Schultze-Lutter et al., 2007). Thirdly, the FEP patients
included in the present work had been exposed to antipsychotic med-
ication for a period of time falling within the range for which effects of
medication have been previously described (Dazzan et al., 2005; Girgis
et al., 2006; Leung et al., 2011). Although these effects have mainly
been detected in striato-limbic regions it is not possible to exclude
that antipsychotic effects on brain structure had already occurred in
these FEP patients. Nevertheless, it is unlikely that the alteration in
the right STG observed both in the ARMS and FEP groups was driven
by the impact of medication, since only two subjects with an ARMS
had been medicated; furthermore, we found no evidence that cortical
thickness in the right STG and right PCC was associated with antipsy-
chotic medication.
In conclusion, cortical thinning in the right STG was present in both
individuals at high risk of developing psychosis and patients with a
ﬁrst episode of the disorder, and therefore is likely to represent a
marker of vulnerability. In contrast, the cingulate cortex showed corti-
cal thinning in FEP patients relative to individuals at high risk, and
therefore appears to be implicated in the onset of the disease. These
neuroanatomical differences were expressed in terms of cortical thick-
ness but not in terms of grey matter volume, and therefore may reﬂect
speciﬁc cortical atrophy as opposed to variations in sulcal and gyral
morphology.
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